BioXcel Therapeutics (BTAI) Gross Profit (2022 - 2026)
BioXcel Therapeutics (BTAI) recorded quarterly Gross Profit of -$77000.0 in Q1 2026, down 134.38% quarter-over-quarter from $224000.0 in Q4 2025, and down 150.0% on a YoY basis from $154000.0 in Q1 2025.
BioXcel Therapeutics (BTAI) Gross Profit (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Gross Profit history runs 5 years deep, the most recent figure standing at -$77000.0 for Q1 2026.
- In Q1 2026, Gross Profit fell 150.0% year-over-year to -$77000.0; the TTM figure through Mar 2026 stood at $247000.0 (up 209.29% YoY), while the FY2025 annual figure was $478000.0, up 288.62% from the prior year.
- Gross Profit was -$77000.0 for Q1 2026 at BioXcel Therapeutics, down from $224000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $1.0 million in Q2 2024 to a low of -$956000.0 in Q3 2024.
- Historically, Gross Profit has averaged $66466.7 across 5 years, with a median of $126000.0 in 2022.
- Biggest YoY gain for Gross Profit was 154.82% in 2024; the steepest drop was 459.06% in 2024.
- A 5-year view of Gross Profit shows it stood at $229000.0 in 2022, then plunged by 247.6% to -$338000.0 in 2023, then slumped by 37.87% to -$466000.0 in 2024, then jumped by 148.07% to $224000.0 in 2025, then slumped by 134.38% to -$77000.0 in 2026.
- The last three Gross Profit figures came in at -$77000.0 (Q1 2026), $224000.0 (Q4 2025), and $87000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | BioXcel Therapeutics | 27.11 Mn | 27.11 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77,000.00 |
| Mar 31, 2026 | -77,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | -466,000.00 |
| Dec 31, 2024 | -466,000.00 |
| Sep 30, 2024 | -956,000.00 |
| Sep 30, 2024 | -956,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 502,000.00 |
| Mar 31, 2024 | 502,000.00 |
| Dec 31, 2023 | -338,000.00 |
| Dec 31, 2023 | -338,000.00 |